[1]
N. Kaur and Soban Sadiq, “Exploring the metabolic adverse effects induced by Nilotinib in adult patients diagnosed with Chronic Myeloid Leukaemia – A Scoping Review ”, AJPP, vol. 5, no. 2, pp. 62–63, Nov. 2025.